Klaus Witte
individual
About
Klaus Witte is a German pharmacology and toxicology expert associated with Insilico Medicine as a scientific advisor/consultant. Public sources link him to preclinical work on INS018_055, an AI-discovered fibrosis drug candidate, and list him as a member of the German Society of Pharmacology & Toxicology and Ethics Commission II at the University of Heidelberg. No credible evidence surfaced that he operates a fund or deploys personal capital as an investor.
Areas of interest
biotechAI drug discoverypharmacologytoxicologyfibrosisaging-related diseasesdrug development